Please provide your email address to receive an email when new articles are posted on . Published findings report that, for vascular access in hemodialysis, the creation of an arteriovenous fistula ...
The US Food and Drug Administration (FDA) has cleared two minimally invasive, catheter-based devices to create arteriovenous (AV) fistulas percutaneously in patients with chronic kidney disease who ...
Briefly, this is how the AV fistula operation is performed: After ad-ministering local anesthesia, the surgeon makes a small incision over the patient’s radial pulse, mobilizes the radial artery, and ...
An AV fistula may fail for various reasons, including low or poor blood flow, failure to mature, excessive pain, a sclerotic vein, and a thrombotic vein. Failure can be disheartening to a patient who ...
WASHINGTON--(BUSINESS WIRE)--The FDA-approved Ellipsys® Vascular Access System from Avenu Medical, Inc., became a key focus of attention throughout last week’s Controversies in Dialysis Access (CiDA) ...
DURHAM, N.C., April 11, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial ...
The Progressive Healthworkers Forum, a coalition of multidisciplinary healthcare professionals, is offering free AV fistula surgeries to chronic kidney disease patients across Delta State to mark ...
Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it will host ...
The endoscopic device manufactured by Maquet was originally developed for harvesting of the saphenous vein and radial artery as conduits for coronary artery bypass graft surgery. These vessels are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results